Overall, our findings suggested that HnRNP A1 - regulated aberrant alternative splicing of CCDC50 could contribute to the carcinogenesis and progression of ccRCC by modulating ZNF395. The gene discussed is CCDC50; the disease is nonpapillary renal cell carcinoma.